Literature DB >> 25700844

Potential mechanisms mediating improved glycemic control after bariatric/metabolic surgery.

Hiroshi Yamamoto1, Sachiko Kaida2, Tsuyoshi Yamaguchi2, Satoshi Murata2, Masaji Tani2, Tohru Tani3.   

Abstract

Conservative medical treatment for morbid obesity generally fails to sustain weight loss. On the other hand, surgical operations, so-called bariatric surgery, have evolved due to their long-term effects. The global increase in the overweight population and the introduction of laparoscopic surgery have resulted in the use of bariatric surgery spreading quickly worldwide in recent years. Recent clinical evidence suggests that bariatric surgery not only reduces body weight, but also improves secondary serious diseases, including type 2 diabetes mellitus, in so-called metabolic surgery. Moreover, several potential mechanisms mediating the improvement in glycemic control after bariatric/metabolic surgery have been proposed based on the animal and human studies. These mechanisms include changes in the levels of gastrointestinal hormones, bacterial flora, bile acids, intestinal gluconeogenesis and gastrointestinal motility as well as adipose tissue and inflammatory mediators after surgery. The mechanisms underlying improved glycemic control are expected to accelerate the promotion of both metabolic and bariatric surgery. This article describes the current status of bariatric surgery worldwide and in Japan, reviews the accumulated data for weight loss and diabetic improvements after surgery and discusses the potential mechanisms mediating improved glycemic control.

Entities:  

Keywords:  Bariatric surgery; Diabetes; GLP-1 (Glucagon-like peptide-1); Metabolic surgery laparoscopic sleeve gastrectomy

Mesh:

Substances:

Year:  2015        PMID: 25700844     DOI: 10.1007/s00595-015-1134-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  36 in total

1.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

Authors:  Anne Vrieze; Els Van Nood; Frits Holleman; Jarkko Salojärvi; Ruud S Kootte; Joep F W M Bartelsman; Geesje M Dallinga-Thie; Mariette T Ackermans; Mireille J Serlie; Raish Oozeer; Muriel Derrien; Anne Druesne; Johan E T Van Hylckama Vlieg; Vincent W Bloks; Albert K Groen; Hans G H J Heilig; Erwin G Zoetendal; Erik S Stroes; Willem M de Vos; Joost B L Hoekstra; Max Nieuwdorp
Journal:  Gastroenterology       Date:  2012-06-20       Impact factor: 22.682

2.  Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects.

Authors:  J Vidal; A Ibarzabal; F Romero; S Delgado; D Momblán; L Flores; A Lacy
Journal:  Obes Surg       Date:  2008-06-03       Impact factor: 4.129

3.  Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice.

Authors:  Stephanie Troy; Maud Soty; Lara Ribeiro; Laure Laval; Stéphanie Migrenne; Xavier Fioramonti; Bruno Pillot; Veronique Fauveau; Roberte Aubert; Benoit Viollet; Marc Foretz; Jocelyne Leclerc; Adeline Duchampt; Carine Zitoun; Bernard Thorens; Christophe Magnan; Gilles Mithieux; Fabrizio Andreelli
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

4.  Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease : a national analysis.

Authors:  Cecily E DuPree; Kelly Blair; Scott R Steele; Matthew J Martin
Journal:  JAMA Surg       Date:  2014-04       Impact factor: 14.766

5.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

6.  The effects of vertical sleeve gastrectomy in rodents are ghrelin independent.

Authors:  Adam P Chambers; Henriette Kirchner; Hilary E Wilson-Perez; Jill A Willency; John E Hale; Bruce D Gaylinn; Michael O Thorner; Paul T Pfluger; Jesus A Gutierrez; Matthias H Tschöp; Darleen A Sandoval; Randy J Seeley
Journal:  Gastroenterology       Date:  2012-09-17       Impact factor: 22.682

7.  Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients.

Authors:  Gianfranco Silecchia; Cristian Boru; Alessandro Pecchia; Mario Rizzello; Giovanni Casella; Frida Leonetti; Nicola Basso
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

8.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

9.  Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.

Authors:  Sunder Mudaliar; Robert R Henry; Arun J Sanyal; Linda Morrow; Hanns-Ulrich Marschall; Mark Kipnes; Luciano Adorini; Cathi I Sciacca; Paul Clopton; Erin Castelloe; Paul Dillon; Mark Pruzanski; David Shapiro
Journal:  Gastroenterology       Date:  2013-05-30       Impact factor: 22.682

10.  Has laparoscopic bariatric surgery been accepted in Japan? The experience of a single surgeon.

Authors:  Kazunori Kasama; Nobumi Tagaya; Eiji Kanahira; Akiko Umezawa; Tetsuya Kurosaki; Takashi Oshiro; Makoto Ishikawa; Yuka Negishi; Yoshimochi Kurokawa; Norio Suzuki; Yasuharu Kakihara; Shoujirou Taketsuka; Kenji Horie; Tetsuya Nakazato; Eri Kikkawa; Sayuri Kabasawa; Yuko Fukuda; Kazuko Sonoda
Journal:  Obes Surg       Date:  2008-04-09       Impact factor: 4.129

View more
  1 in total

1.  Long-Term Outcomes of Bariatric and Metabolic Surgery in Japan: Results of a Multi-Institutional Survey.

Authors:  Hidenori Haruta; Kazunori Kasama; Masayuki Ohta; Akira Sasaki; Hiroshi Yamamoto; Yasuhiro Miyazaki; Takashi Oshiro; Takeshi Naitoh; Yoshinori Hosoya; Takeshi Togawa; Yosuke Seki; Alan Kawarai Lefor; Toru Tani
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.